Article
Functional impact of glycosylation of LRIG1 on EGFR proteostasis in cancer.
Journal of biochemistry - 11 Mar 2026
Kondo Jumpei, Nagao Himari, Oyama Koki, Minamiura Akari, Aoki Shuto, Sakon Daisuke, Nakayama Honoka, Takamatsu Shinji, Miyoshi Eiji
Abstract excerpt
LRIG1, a membrane glycoprotein, has emerged as a significant stem cell marker and negative regulator of receptor tyrosine kinases (RTKs), including epidermal growth factor receptor (EGFR). Glycosylation is a major post-translational modification, which plays a crucial role in protein function and stability. In cancer biology, abnormal glycosylation can contribute to pathogenesis, which can also serve as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
